Zhifei Biological and GSK Sign Exclusive Distribution and Co-Promotion Agreement for Recombinant Zoster Vaccine

36Kr learned that Chongqing Zhifei Biological Products Co., Ltd. announced on October 8 that the company had signed an "Exclusive Distribution and Co-Promotion Agreement" with GSK Biologicals and GSK Hong Kong (GSK). GSK will exclusively supply Zhifei Biological with its recombinant shingles vaccine and authorize Zhifei Biological to market, promote, import, and distribute the relevant products within the agreed cooperation area. In addition, the agreement stipulates that GSK will be the exclusive partner of Zhifei Biological for the co-development and commercialization of any RSV vaccines for the elderly within the cooperation area. The term of the agreement is from October 8, 2023, to December 31, 2026.Original Link